申请人:TriVascular, Inc.
公开号:EP2915549A1
公开(公告)日:2015-09-09
Hydrogel compositions prepared from amine components and glycidyl ether components are provided which are biocompatible and suitable for use in vivo due, in part, to their excellent stability.
由胺成分和缩水甘油醚成分制备的水凝胶组合物具有生物相容性,并且由于其出色的稳定性而适合在体内使用。